FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter DiBattiste

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Devices

Stents

Co-author Network

Publications

TOP 3
Sukit M Ringwala; Peter M DiBattiste; David J Schneider
Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
Peter R Kowey; Ramagopal V Mudumbi; Joseph W Aquilina; Peter M DiBattiste
Cardiovascular safety profile of dapoxetine during the premarketing evaluation.
Aaron D Kugelmass; Saihari Sadanandan; Nasser Lakkis; Peter M DiBattiste; Debbie H Robertson; Laura A Demopoulos; C Michael Gibson; William S Weintraub; Sabina A Murphy; Christopher P Cannon
Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter DiBattiste (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sukit M Ringwala; Peter M DiBattiste; David J Schneider
Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
Journal of thrombosis and thrombolysis 2012;34(3):291-6.
2011: Peter R Kowey; Ramagopal V Mudumbi; Joseph W Aquilina; Peter M DiBattiste
Cardiovascular safety profile of dapoxetine during the premarketing evaluation.
Drugs in R&D 2011;11(1):1-11.
2006: Aaron D Kugelmass; Saihari Sadanandan; Nasser Lakkis; Peter M DiBattiste; Debbie H Robertson; Laura A Demopoulos; C Michael Gibson; William S Weintraub; Sabina A Murphy; Christopher P Cannon
Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
Critical pathways in cardiology 2006;5(3):167-72.
2006: Jack L Martin; Gang Jia; Seth S Martin; Timothy A Shapiro; Howard C Herrmann; Peter M DiBattiste; Eric J Topol; David J Moliterno
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(4):563-70.
2005: Benjamin A Steinberg; Alexandria J M Braganza; Gemma Eminowicz; Peter M DiBattiste; Gregory C Flaker; Sabina A Murphy; Christopher P Cannon
Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18.
Critical pathways in cardiology 2005;4(4):169-73.
2005: Erik Ohman; Frans Van de Werf; Elliott M Antman; Robert M Califf; James A de Lemos; C Michael Gibson; Renee L Oliverio; Lynn Harrelson; Carolyn McCabe; Peter M DiBattiste; Eugene Braunwald
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
American heart journal 2005;150(1):79-88.
2005: Peter B Berger; Patricia J M Best; Eric J Topol; Jennifer White; Peter M DiBattiste; Albert W Chan; Steen Dalby Kristensen; Howard C Herrmann; David J Moliterno
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.
American heart journal 2005;149(5):869-75.
2005: Jessica L Mega; David A Morrow; Marc S Sabatine; Xue-Qiao Zhao; Steven M Snapinn; Peter M DiBattiste; C Michael Gibson; Elliott M Antman; Eugene Braunwald; Pierre Théroux
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
American heart journal 2005;149(5):846-50.
2005: thao huynh; Nicolo Piazza; Peter M DiBattiste; Steven M Snapinn; Ying Wan; Chantal Pharand; Pierre Theroux
Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
International journal of cardiology 2005;100(1):73-8.
2005: Hisham Dokainish; Manu Pillai; Sabina A Murphy; Peter M DiBattiste; Marc J Schweiger; Amir Lotfi; David A Morrow; Christopher P Cannon; Eugene Braunwald; Nasser Lakkis
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Journal of the American College of Cardiology 2005;45(1):19-24.
2004: Juhana Karha; C Michael Gibson; Sabina A Murphy; Peter M DiBattiste; Christopher P Cannon
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction.
The American journal of cardiology 2004;94(12):1537-9.
2004: Saihari Sadanandan; Christopher P Cannon; C Michael Gibson; Sabina A Murphy; Peter M DiBattiste; Eugene Braunwald
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(4):799-803.
2004: C Michael Gibson; Kanwar P Singh; Sabina A Murphy; Peter M DiBattiste; Laura A Demopoulos; Christopher P Cannon; Eugene Braunwald
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).
The American journal of cardiology 2004;94(4):492-4.
2004: Saihari Sadanandan; Christopher P Cannon; Kasi Chekuri; Sabina A Murphy; Peter M DiBattiste; David A Morrow; James A de Lemos; Eugene Braunwald; C Michael Gibson
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(3):564-8.
2004: Richard G Bach; Christopher P Cannon; William S Weintraub; Peter M DiBattiste; Laura A Demopoulos; H Vernon Anderson; Paul T DeLucca; Elizabeth M Mahoney; Sabina A Murphy; Eugene Braunwald
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes.
Annals of internal medicine 2004;141(3):186-95.
2004: Deepak Talreja; Dieter Lubbe; James L Orford; Ryan J Lennon; Peter M DiBattiste; Peter B Berger
Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregometry study.
Journal of thrombosis and thrombolysis 2004;18(1):25-30.
2004: Michael A Blazing; James A de Lemos; Harvey D White; Keith A A Fox; Freek W A Verheugt; Diego Ardissino; Peter M DiBattiste; Joanne Palmisano; David W Bilheimer; Steven M Snapinn; Karen E Ramsey; Laura H Gardner; Vic Hasselblad; Marc A Pfeffer; Eldrin F Lewis; Eugene Braunwald; Robert M Califf
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: Howard C Herrmann; Sabina A Murphy; Peter M DiBattiste; Paul T Delucca; Laura A Demopoulos; C Michael Gibson; Christopher P Cannon
Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
Critical pathways in cardiology 2004;3(2):95-100.
2004: Peter A McCullough; C Michael Gibson; Peter M DiBattiste; Laura A Demopoulos; Sabina A Murphy; William S Weintraub; Franz-Josef Neumann; Sanjaya Khanal; Christopher P Cannon
Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial.
Journal of interventional cardiology 2004;17(2):81-6.
2004: Stephen J Servoss; Ying Wan; Steven M Snapinn; Peter M DiBattiste; Xue-Qiao Zhao; Pierre Theroux; Ik-Kyung Jang; James L Januzzi
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial.
The American journal of cardiology 2004;93(7):843-7.
2004: Marc S Sabatine; David A Morrow; Robert P Giugliano; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; William S Weintraub; Carolyn H McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Circulation 2004;109(7):874-80.
2004: Stephen D Wiviott; Christopher P Cannon; David A Morrow; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Marc S Sabatine; Nader Rifai; Robert P Giugliano; Peter M DiBattiste; Laura A Demopoulos; Elliott M Antman; Eugene Braunwald
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Circulation 2004;109(5):580-6.
2003: Albert W Chan; David J Moliterno; Peter B Berger; Gregg W Stone; Peter M DiBattiste; Steven L Yakubov; Shelly K Sapp; Kathy Wolski; Deepak L Bhatt; Eric J Topol
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
Journal of the American College of Cardiology 2003;42(7):1188-95.
2003: Mitchell J Ross; Howard C Herrmann; David J Moliterno; James C Blankenship; Laura A Demopoulos; Peter M DiBattiste; Stephen G Ellis; Ziyad Ghazzal; Jack L Martin; Jennifer White; Eric J Topol
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
Journal of the American College of Cardiology 2003;42(6):981-8.
2003: Ivan P Casserly; Eric J Topol; Gang Jia; Richard A Lange; Christian Hamm; Bernhard Meier; Peter M DiBattiste; Nasser Lakkis; Derek P Chew; Gregg W Stone; David J Cohen; David J Moliterno
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial.
The American journal of cardiology 2003;92(2):125-9.
2003: Graham C Wong; Daniel Frisch; Sabina A Murphy; Marc S Sabatine; Rupal Pai; David James; Nicole Kraimer; Peter T Katsiyiannis; Susan J Marble; Peter M DiBattiste; Laura A Demopoulos; Steven G Gourlay; Hal V Barron; Christopher P Cannon; C Michael Gibson
Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction.
The American journal of cardiology 2003;91(10):1163-7.
2003: David A Morrow; James A de Lemos; Marc S Sabatine; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Eugene Braunwald
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
Journal of the American College of Cardiology 2003;41(8):1264-72.
2003: Duane S Pinto; David P Lorenz; Sabina A Murphy; Susan J Marble; Peter M DiBattiste; Laura A Demopoulos; Christopher P Cannon; C Michael Gibson
Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy).
The American journal of cardiology 2003;91(8):976-8, A4.
2003: David P Lee; Niall A Herity; Bonnie L Hiatt; William F Fearon; Mehrdad Rezaee; Andrew J Carter; Michelle Huston; Donald Schreiber; Peter M DiBattiste; Alan C Yeung
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial.
Circulation 2003;107(11):1497-501.
2003: James L Januzzi; Marc S Sabatine; Ying Wan; Stephen J Servoss; Peter M DiBattiste; Ik-Kyung Jang; Pierre Theroux
Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy.
The American journal of cardiology 2003;91(4):457-61.
2003: David J Schneider; Howard C Herrmann; Nasser Lakkis; Frank Aguirre; Man-Wai Lo; Kuo Chang Yin; Atul Aggarwal; Samer S Kabbani; Peter M DiBattiste
Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban.
The American journal of cardiology 2003;91(3):334-6.
2002: Ruchira Glaser; Howard C Herrmann; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Christopher P Cannon; Eugene Braunwald
Benefit of an early invasive management strategy in women with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;288(24):3124-9.
2002: David J Schneider; Howard C Herrmann; Nasser Lakkis; Frank Aguirre; Ying Wan; Atul Aggarwal; Samer S Kabbani; Peter M DiBattiste
Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban.
The American journal of cardiology 2002;90(12):1421-3.
2002: Nasser Lakkis; Valeri Tsyboulev; C Michael Gibson; Sabina A Murphy; William S Weintraub; Peter M DiBattiste; Christopher P Cannon
Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy.
Critical pathways in cardiology 2002;1(4):232-7.
2002: James L Januzzi; Christopher P Cannon; Peter M DiBattiste; Sabina Murphy; William Weintraub; Eugene Braunwald
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).
The American journal of cardiology 2002;90(11):1246-9.
2002: Marc S Sabatine; David A Morrow; Christopher P Cannon; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Carolyn H McCabe; Eugene Braunwald; C Michael Gibson
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Journal of the American College of Cardiology 2002;40(10):1761-8.
2002: Elizabeth M Mahoney; Claudine Jurkovitz; Haitao Chu; Edmund R Becker; Steven D Culler; Andrzej S Kosinski; Debbie H Robertson; Charles Alexander; Soma Nag; John R Cook; Laura A Demopoulos; Peter M DiBattiste; Christopher P Cannon; William S Weintraub
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
JAMA : the journal of the American Medical Association 2002;288(15):1851-8.
2002: Neal S Kleiman; Nasser Lakkis; Christopher P Cannon; Sabina A Murphy; Peter M DiBattiste; Laura A Demopoulos; William S Weintraub; Eugene Braunwald
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
Journal of the American College of Cardiology 2002;40(6):1044-50.
2002: Wayne B Batchelor; Thaddeus R Tolleson; Yao Huang; Rhonda L Larsen; R Michael Mantell; Patricia Dillard; Marie Davidian; Daowen Zhang; Warren J Cantor; Michael H Sketch; Erik Ohman; James P Zidar; Daniel Gretler; Peter M DiBattiste; James E Tcheng; Robert M Califf; Robert A Harrington
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Circulation 2002;106(12):1470-6.
2002: Sorin J Brener; Sabina A Murphy; C Michael Gibson; Peter M DiBattiste; Laura A Demopoulos; Christopher P Cannon
Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.
The American journal of cardiology 2002;90(6):631-3.
2002: David J Moliterno; Steven J Yakubov; Peter M DiBattiste; Howard C Herrmann; Gregg W Stone; Carlos Macaya; Franz-Josef Neumann; Diego Ardissino; Jean-Pierre Bassand; Lynn Borzi; Alan C Yeung; Katherine A Harris; Laura A Demopoulos; Eric J Topol
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.
Lancet 2002;360(9330):355-60.
2002: Graham C Wong; David A Morrow; Sabina Murphy; Nicole Kraimer; Rupal Pai; David James; Debbie H Robertson; Laura A Demopoulos; Peter M DiBattiste; Christopher P Cannon; C Michael Gibson
Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.
Circulation 2002;106(2):202-7.
2002: Marco Roffi; David J Moliterno; Bernhard Meier; Eric Randall Powers; Cindy L Grines; Peter M DiBattiste; Howard C Herrmann; Michel Bertrand; Katherine E Harris; Laura A Demopoulos; Eric J Topol
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.
Circulation 2002;105(23):2730-6.
2002: Howard C Herrmann; Tomasz A Swierkosz; Shiv Kapoor; Danielle C Tardiff; Peter M DiBattiste; John W Hirshfeld; Bruce D Klugherz; Daniel M Kolansky; Kathleen Magness; Nicholas Valettas; Robert L Wilensky
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.
The American journal of cardiology 2002;89(11):1293-7.
2002: James L Januzzi; Steven M Snapinn; Peter M DiBattiste; Ik-Kyung Jang; Pierre Theroux
Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
Circulation 2002;105(20):2361-6.
2002: Gregg W Stone; David J Moliterno; Michel Bertrand; Franz-Josef Neumann; Howard C Herrmann; Eric Randall Powers; Cindy L Grines; Jeffrey W Moses; David J Cohen; Eric A Cohen; Marc Cohen; Kathy Wolski; Peter M DiBattiste; Eric J Topol
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
Circulation 2002;105(20):2347-54.
2002: Samer S Kabbani; Atul Aggarwal; Edward F Terrien; Peter M DiBattiste; Burton E Sobel; David J Schneider
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.
The American journal of cardiology 2002;89(5):647-50.
2001: David A Morrow; Christopher P Cannon; Nader Rifai; MJ Frey; R Vicari; Nasser Lakkis; Debbie H Robertson; D A Hille; Paul T DeLucca; Peter M DiBattiste; Laura A Demopoulos; William S Weintraub; Eugene Braunwald
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.
JAMA : the journal of the American Medical Association 2001;286(19):2405-12.
2001: Eric J Topol; David J Moliterno; Howard C Herrmann; Eric Randall Powers; Cindy L Grines; D J Cohen; Eric A Cohen; M Bertrand; Franz-Josef Neumann; Gregg W Stone; Peter M DiBattiste; Laura A Demopoulos
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
The New England journal of medicine 2001;344(25):1888-94.
2001: Christopher P Cannon; William S Weintraub; Laura A Demopoulos; R Vicari; MJ Frey; Nasser Lakkis; Franz-Josef Neumann; Debbie H Robertson; Paul T DeLucca; Peter M DiBattiste; C Michael Gibson; Eugene Braunwald
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
The New England journal of medicine 2001;344(25):1879-87.